Technology
Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research
Indivumed and the Oslo University Hospital's Institute for Cancer Genetics and Informatics will develop algorithms to automate colorectal cancer prognoses.
Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study
Researchers identified several pre-treatment markers that correlated with T-cell expansion and could be predictive of response to a PD1 inhibitor.
GE Healthcare Acquiring Zionexa for Access to Breast Cancer PET Imaging Agent
GE intends to scale access to the PET imaging agent so at least 75 percent of metastatic breast cancer patients in the US have access to it by 2023.
FDA Approves Keytruda-Herceptin Combination for HER2-Positive Gastric, Gastroesophageal Cancer
The agency granted accelerated approval to Merck's pembrolizumab plus Herceptin and chemotherapy for patients with advanced, HER2-positive gastric cancer.
AstraZeneca, Alchemab Partner on Prostate Cancer Immunotherapy Research
UK-based Alchemab will use its platform to sequence the antibody repertoires of prostate cancer patients treated within an AstraZeneca immunotherapy trial.